Pure Global AI
NCT05962710Terminated

FreeStyle Libre 3 Continuous Glucose Monitoring System

FreeStyle Libre 3 Continuous Glucose Monitoring System Confirmation Study
Abbott Diabetes CareClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Diabetes Mellitus
Drug/Device/Intervention
FreeStyle Libre 3
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Abbott Diabetes Care
Location
Santa Barbara,Idaho Falls,San Antonio,Renton, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jan 27, 2023
End date
Jan 31, 2023
Enrollment
7 participants
Primary outcome

System Performance

Summary

The purpose of this study is to characterize the FreeStyle Libre 3 Continuous Glucose
 Monitoring System performance with respect to YSI reference venous plasma sample
 measurements.

ICD-10 classifications
Diabetes mellitusUnspecified diabetes mellitusOther specified diabetes mellitusUnspecified diabetes mellitus without complicationsUnspecified diabetes mellitus with unspecified complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05962710
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05962710 through Pure Global AI's free database. This phase not specified trial is sponsored by Abbott Diabetes Care and is currently Terminated. The study focuses on Diabetes Mellitus. Target enrollment is 7 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.